Clinical Trial Update: A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

View source ↗

Summary

A completed real-world database study sponsored by Pfizer aims to characterize patients with advanced or metastatic breast cancer who are treated with palbocicl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (Ibrance) (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Advanced or Metastatic Breast Cancer | Status: COMPLETED